A Phase I First in Human Study Evaluating Safety and Efficacy of ABBV-155 Monotherapy and Combined with Docetaxel in Adult Patients with Relapsed and Refractory Solid Tumors.

Who We ARE:
Advocacy - Your Voice in State & National Advocacy
Relationships - Your Partner in Cancer Care
Education: Administration, Business, Clinical

JOIN OR RENEW NOW